George Millen: Unscripted

The global Edtech firm's prestigious accreditation signals a new era of accountability, forcing a reckoning on quality in the online tutoring market.

For the fifth year, Cintas is a Forbes 'Best Employer.' We look inside the culture, the critiques, and how it gives the company a strategic market advantage.

LS Power Grid California breaks ground on the Manning Substation, a key project to enhance grid reliability and accelerate the state's clean energy goals.

Robert Herjavec invests in AI firm Lovelytics, betting on the critical need for data infrastructure and aiming to scale the top Databricks partner.

As Matricelf presents its breakthrough therapy at a major summit, the company moves closer to human trials, offering new hope for paralysis patients.

Labour unions and students decry the Ford government's plan to shift OSAP from grants to loans, warning of crippling debt and reduced access to education.

Major outages are often caused by simple network config errors, not data loss. A new approach to disaster recovery targets this overlooked vulnerability.

A new partnership with ULTRA RED shifts cybersecurity from periodic scans to a continuous, validation-first model, slashing alerts and speeding up fixes.

Digital marketplace Whop is integrating Tether's stablecoins for millions of users, a major push for real-world crypto adoption facing global regulatory tests.

Aera Technology's 'agentic AI' lands on The Hackett Group's '50 to Watch' list, promising to automate complex supply chain decisions in real time.

Advantage Solutions overhauls its board, adding heavyweights in capital markets and commercial strategy to navigate a pivotal transformation and retail industry shifts.

P4ML joins the Orphan Therapeutics Accelerator to bring shelved cures to patients, leveraging a new non-profit model and expanding access to the MENA region.

New FDA-cleared Persona PLUS technology promises to increase plasma yields per donor, tackling the growing global demand for life-saving therapies.

Komar Industries' acquisition of Metro Compactor creates a cross-border powerhouse, combining U.S. manufacturing with Canadian service and IoT technology.

Dupixent's landmark FDA approval offers a new, surgery-sparing option for a debilitating sinus disease, but questions of access and cost remain.

In a key strategic hire, AXA XL has appointed AIG veteran Greg Carnazza to lead its Americas Construction Property division amid complex industry risks.

As Autolus heads to key investor conferences, its strong AUCATZYL® sales and deep pipeline face scrutiny against mounting losses and a curious PR misstep.

US consumers are sitting on $83B in unused tech. New research shows why brands failing to offer good trade-in programs are losing revenue and loyalty.

As stablecoin rules tighten, a new partnership between Circle and CyberScope signals a major shift towards institutional-grade security in Web3.

The new 'Suppies' awards aim to simplify the confusing supplement market, but do they offer true clarity or just clever marketing? We investigate.